Invesco DB Agriculture Fund vs Philip Morris International Inc. — how do they compare? Invesco DB Agriculture Fund trades at $27.33, while Philip Morris International Inc. trades at $176.88 (market cap $280.84B). The key difference: Philip Morris International Inc. pays a 3.26% dividend while Invesco DB Agriculture Fund pays none, and Philip Morris International Inc. is trading nearer its 52-week high, Invesco DB Agriculture Fund nearer its low. Which is the better fit depends on your goals.
| DBA | PM | |
|---|---|---|
52-Week High | $28.73 | $191.86 |
52-Week Low | $25.44 | $144.33 |
Market Cap | — | $280.84B |
Sector | — | Consumer Staples |
Enterprise Value | — | $327.33B |
Dividend Yield | — | 3.26% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 3.12% on the day, amid a recent profit forecast revision. The stock shows a bullish technical signal with key support at $175 and resistance at $183. Fundamentally, the company reported strong 2025 results with $40.65B revenue and $11.35B net income, though a $500M impairment charge and cost pressures prompted a lowered 2026 outlook. Analyst sentiment remains positive with a $194 consensus price target and 68% buy ratings.
The outlook is cautiously optimistic; earnings growth and the IQOS brand strength offer upside, but regulatory risks and illicit market pressures pose challenges. The current price presents a potential entry point below the analyst target, though investors must weigh margin pressures from energy costs and currency swings noted in recent company guidance.
Trailing returns across standard periods
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →